Metabolic effects of dialyzate glucose in chronic hemodialysis: results from a prospective, randomized crossover trial

BORIS DOI
Publisher DOI
PubMed ID
21940484
Description
There is no agreement concerning dialyzate glucose concentration in hemodialysis (HD) and 100 and 200 mg/dL (G100 and G200) are frequently used. G200 may result in diffusive glucose flux into the patient, with consequent hyperglycemia and hyperinsulinism, and electrolyte alterations, in particular potassium (K) and phosphorus (P). This trial compared metabolic effects of G100 versus G200.
Date of Publication
2012
Publication Type
Article
Language(s)
en
Contributor(s)
Raimann, Jochen G
Thijssen, Stephan
Kuntsevich, Viktoriya
Dabel, Pascal
Bachar, Mostafa
Diaz-Buxo, Jose A
Levin, Nathan W
Kotanko, Peter
Additional Credits
Universitätsklinik für Nephrologie, Hypertonie und Klinische Pharmakologie
Series
Nephrology, dialysis, transplantation
Publisher
Oxford University Press
ISSN
0931-0509
Access(Rights)
open.access
Show full item